Roopa Mehta MDMetabolic Diseases Research Unit (UIEM), Department of Endocrinology, National Institute of Medical Sciences and Nutrition Salvador Zubirán (INCMNSZ), Mexico City, Mexico
Roopa Mehta is an endocrinologist and researcher in the Department of Endocrinology and Metabolism at the INCMNSZ. She is also a physician at the Hospital Angeles Pedregal and the American British Cowdray Medical Center, Mexico City. She is an Associate Professor in both pre- and postgraduate endocrinology programs, and is an investigator for phase 2 and phase 3 clinical trials. Dr Mehta undertook her medical training at the United Medical and Dental Schools of Guy’s and St Thomas’ Hospitals, London, UK. She subsequently trained as an endocrinologist at the INCMNSZ. On completing the residency program, Dr Mehta subspecialized in diabetes and metabolism and gained further clinical and investigative experience rotating at the Joslin Diabetes Center, Boston, MA, USA. She holds a Masters of Medical Sciences from the National Autonomous University of Mexico, Mexico City.
Dr Mehta's research interests focus on Type 2 diabetes mellitus (clinical investigation), metabolic syndrome and lipid metabolism (in particular evaluation of cardiovascular risk and familial hypercholesterolemia). She co-ordinates the cardiovascular research laboratory in the UIEM and the lipid clinic in her hospital.
She has presented at symposiums including the American Diabetes Association, European Association for the Study of Diabetes, and American Association of Clinical Endocrinologists (AACE) meetings and has also presented her research (posters) in national and international meetings. Dr Mehta is an Associate Editor for Diabetes Medicine and a reviewer for Diabetes Therapy. She has received the Alfonso Rivera Research Award and the Young Investigator Award from the AACE. Dr Mehta has authored and co-authored publications in international journals in addition to numerous book chapters. She is a co-editor of a book for patients, Living with Diabetes: A Practical Manual.
DisclosuresDr. Mehta discloses the following:
- Advisor - Novo Nordisk, Boehringer Ingelheim, Amgen, AstraZeneca, Abbott, Eli Lilly, Sanofi
- Speakers Bureau - Novo Nordisk, Boehringer Ingelheim, Amgen, AstraZeneca, Abbott, Eli Lilly, Silanes